Actively Recruiting
Impact of the Digital Multi-domain Cognitive Intervention in High-risk Populations for Dementia
Led by Fujian Provincial Hospital · Updated on 2024-09-19
128
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Dementia is a chronic, progressive neurodegenerative disease characterized by acquired cognitive impairment as its core manifestation. The most common type of dementia is Alzheimer's Disease (AD), also known as "Senile Dementia," accounting for 60-80% of all dementia cases. Currently, there are approximately 10 million AD patients in China, with the number showing an increasing trend year by year, imposing a heavy economic and caregiving burden on families and society. Studies have shown that AD has a clinically silent period of 15 to 20 years (SCD\\MCI), where the risk of developing dementia is ten times higher than that of healthy elderly individuals. Nearly 50% of MCI patients progress to dementia within 5 years, and about 14.1% of SCD patients develop dementia within the same timeframe. Early detection, diagnosis, and intervention are currently the most effective strategies for preventing and treating AD. Therefore, this study aims to verify the intervention effect of integrated cognitive intervention in high-risk populations for senile dementia (SCD, MCI) based on the cognitive rehabilitation model through randomized controlled trials, and to analyze attrition rates, participation rates, etc., which have good research and application value.
CONDITIONS
Official Title
Impact of the Digital Multi-domain Cognitive Intervention in High-risk Populations for Dementia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) according to specific diagnostic criteria
- Able to communicate normally in Mandarin
- Have adequate comprehension and judgment to understand the study purpose and provide consent to participate
You will not qualify if you...
- Diagnosed with dementia exhibiting abnormal mental behavior
- Severe hearing or speech impairments
- Serious physical illnesses preventing cooperation or completion of the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fujian Provincial Hospital
Fuzhou, Fujian, China, 350001
Actively Recruiting
Research Team
L
lian fayang, MD
CONTACT
Y
Yuanjiao Yan, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here